HK1257590A1 - Medicine for preventing and treating medicinal kidney injury and the use of the medicine - Google Patents

Medicine for preventing and treating medicinal kidney injury and the use of the medicine

Info

Publication number
HK1257590A1
HK1257590A1 HK18116709.8A HK18116709A HK1257590A1 HK 1257590 A1 HK1257590 A1 HK 1257590A1 HK 18116709 A HK18116709 A HK 18116709A HK 1257590 A1 HK1257590 A1 HK 1257590A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
kidney injury
treating medicinal
medicinal
Prior art date
Application number
HK18116709.8A
Other languages
Chinese (zh)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257590A1 publication Critical patent/HK1257590A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116709.8A 2016-12-15 2018-12-28 Medicine for preventing and treating medicinal kidney injury and the use of the medicine HK1257590A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611162270 2016-12-15
CN201611162257 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257590A1 true HK1257590A1 (en) 2019-10-25

Family

ID=62658161

Family Applications (3)

Application Number Title Priority Date Filing Date
HK18116709.8A HK1257590A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating medicinal kidney injury and the use of the medicine
HK18116705.2A HK1257586A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating kidney fibrosis and use of the medicine
HK18116710.5A HK1257591A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK18116705.2A HK1257586A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating kidney fibrosis and use of the medicine
HK18116710.5A HK1257591A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine

Country Status (2)

Country Link
CN (3) CN108210908A (en)
HK (3) HK1257590A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201902419D0 (en) * 2019-02-22 2019-04-10 Singapore Health Serv Pte Ltd Treatment of kidney injury
CN115551534A (en) * 2020-02-26 2022-12-30 泰伦基国际有限公司 Method and medicine for preventing and treating abnormal blood pressure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2779905A1 (en) * 2009-11-07 2011-05-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Also Published As

Publication number Publication date
CN108210894A (en) 2018-06-29
HK1257591A1 (en) 2019-10-25
CN108210908A (en) 2018-06-29
HK1257586A1 (en) 2019-10-25
CN108210893A (en) 2018-06-29

Similar Documents

Publication Publication Date Title
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
IL260771B1 (en) Catheter locking solution and catheter locking therapy
IL258854A (en) Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
PT3227237T (en) Device and use thereof for the uv treatment of fluids
EP3544654C0 (en) Device for the repetitive supply and draining of substances for medical therapy
HK1257239A1 (en) Medicine for preventing and treating obesity and use of the medicine
GB201617064D0 (en) Compounds and their therapeutic use
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof
HK1257585A1 (en) Medicine for preventing and treating skin fibrosis and use of the medicine
IL266486A (en) Pharmaceutical compositions and methods for the treatment of cancer
IL259035A (en) Oxadiazaspiro compounds for the treatment of drug abuse and addiction
GB201519557D0 (en) Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
IL272097A (en) Compounds for the prevention and treatment of medical disorders and uses thereof
IL265824A (en) Methods and pharmaceutical compositions for the treatment of kidney cancer
EP3723742C0 (en) Use of fluoroethylnormemantine for the prevention and treatment of anxiety
HK1257590A1 (en) Medicine for preventing and treating medicinal kidney injury and the use of the medicine
EP3156054A4 (en) Medicine for preventing and/or treating stress-induced diseases
HK1257238A1 (en) Medicine for preventing and treating lipid kidney injury and use of the medicine
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
IL259383A (en) Compound for use in the prevention and treatment of neurodegenerative diseases
EP3525771A4 (en) Prevention and/or treatment of contrast-induced acute kidney injury
EP3400025C0 (en) The use of guaiacol for the prevention and treatment of glycogen storage disease
FI20145861A (en) Multivalent compounds for use in the treatment and prevention of brain injury
RS65225B1 (en) Medicament for the treatment and/or prevention of endometriosis
HK1251178A1 (en) Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy